1967 Marburg virus disease outbreak

Last updated
1967 Marburg virus disease outbreak
Marburg-distribution-map-crop.png
Disease Marburg virus disease
Virus strain Marburg virus
Location West Germany and Yugoslavia
First outbreak Marburg and Frankfurt
Confirmed cases32
Deaths
7
Territories
2

The 1967 Marburg virus disease outbreak was the first recorded outbreak of Marburg virus disease. [1] It started in early August 1967 when 30 people became ill in the West German towns of Marburg and Frankfurt and later two in Belgrade, Yugoslavia (now Serbia). [2] The infections were traced back to three laboratories in the separate locations which received a shared shipment of infected African green monkeys. [3] The outbreak involved 25 primary Marburg virus infections and seven deaths, and six non-lethal secondary cases. [2]

Contents

Overview

In early August 1967, patients with unusual symptoms indicating an infectious disease were admitted to the university hospitals in Marburg and Frankfurt. The first patients were treated in their homes for up to 10 days, even though the illness was described as beginning suddenly with extreme malaise, myalgia, headache, and a rapid increase in body temperature to as high as 39 °C (102.2 °F) or more. Although the clinical symptoms were not very alarming during the first 3–4 days, additional symptoms and signs appeared at the end of the first week. The patients were therefore admitted to a hospital. In some cases, patients died from severe hemorrhagic shock on the day after hospital admission. Severe hemorrhagic shock occurred in about 25% of patients. All patients who died had hemorrhagic shock. The first infections occurred in laboratory workers who were conducting necropsies on imported African green monkeys. [4]

The incubation time of Marburg virus disease could only be estimated retrospectively, after the source of infection and the date of exposure were known. Incubation ranged from 5 to 9 days, with an average of 8 days. The ratio of primary to secondary infections was 21:3 in Marburg, 4:2 in Frankfurt, and 1:1 in Belgrade. Three cases of secondary infection resulted from inadvertent needle-stick inoculations; in one case, a pathology technician cut himself on the forearm with a knife during a postmortem examination. Airborne transmission between humans did not occur, as indicated, for example, by the instance of a young man who slept in the same bed with his brother only a couple of days before he died; the brother did not develop disease and was seronegative for Marburg virus disease six months later. [3]

Origin

Shipment of infected African green monkeys to three laboratories was the origin of the outbreaks. Zoo des 3 vallees - Vervet 01.jpg
Shipment of infected African green monkeys to three laboratories was the origin of the outbreaks.

The origin of the outbreaks was investigated at the same time as the microbiological studies. Early on in the investigation, it was realized that the patients in Marburg were employees of Behringwerke, a producer of sera and vaccines. The patients in Frankfurt were employees of Paul Ehrlich Institute, a control institute of sera and vaccines. The primary case in Belgrade was an employee involved in testing of live vaccines. All the patients at the three locations had contact with blood, organs, and cell cultures from African green monkeys ( Cercopithecus aethiops ). The monkeys' organs were used to make kidney cell culture for the production and safety testing of vaccines. [3]

The separate outbreaks were traced back to a shared shipment of infected green monkeys. Generally, shipments of green monkeys went directly from Uganda to Frankfurt. However, because of the Six Day War (5–10 June 1967), this shipment of monkeys was rerouted through London, where they were placed in animal storage because of a strike at the airport. After a two day delay, the monkeys were shipped to Frankfurt, and then to the laboratories in Frankfurt, Marburg, and Belgrade in June and July. The subsequent processing of the monkeys for cell culture at the three locations led to the laboratory-related outbreaks. The monkeys were believed to have been infected in Uganda, although infection from other animals in storage in London was also possible. [3]

History

The Marburg virus disease made reappearances in other countries in 1975, 1980, 1987, 1990, 1998–2000, 2004–05, 2007, 2008, 2017 and 2021-24. The seven deaths out of the 31 initially diagnosed infections during the 1967 Marburg virus outbreak represent a case fatality rate of 23%. The 32nd case was diagnosed retroactively via serology. [5]

See also

Related Research Articles

<span class="mw-page-title-main">Lassa fever</span> Viral disease spread by a type of mouse

Lassa fever, also known as Lassa hemorrhagic fever, is a type of viral hemorrhagic fever caused by the Lassa virus. Many of those infected by the virus do not develop symptoms. When symptoms occur they typically include fever, weakness, headaches, vomiting, and muscle pains. Less commonly there may be bleeding from the mouth or gastrointestinal tract. The risk of death once infected is about one percent and frequently occurs within two weeks of the onset of symptoms. Of those who survive, about a quarter have hearing loss, which improves within three months in about half of these cases.

<span class="mw-page-title-main">Marburg virus disease</span> Human viral disease

Marburg virus disease (MVD), formerly Marburg hemorrhagic fever (MHF) is a viral hemorrhagic fever in human and non-human primates caused by either of the two Marburgviruses: Marburg virus (MARV) and Ravn virus (RAVV). Its clinical symptoms are very similar to those of Ebola virus disease (EVD).

Bolivian hemorrhagic fever (BHF), also known as black typhus or Ordog Fever, is a hemorrhagic fever and zoonotic infectious disease originating in Bolivia after infection by Machupo mammarenavirus.

<span class="mw-page-title-main">Viral hemorrhagic fever</span> Type of illnesses

Viral hemorrhagic fevers (VHFs) are a diverse group of animal and human illnesses. VHFs may be caused by five distinct families of RNA viruses: the families Filoviridae, Flaviviridae, Rhabdoviridae, and several member families of the Bunyavirales order such as Arenaviridae, and Hantaviridae. All types of VHF are characterized by fever and bleeding disorders and all can progress to high fever, shock and death in many cases. Some of the VHF agents cause relatively mild illnesses, such as the Scandinavian nephropathia epidemica, while others, such as Ebola virus, can cause severe, life-threatening disease.

<i>The Hot Zone</i> 1995 nonfiction book by Richard Preston

The Hot Zone: A Terrifying True Story is a best-selling 1994 nonfiction thriller by Richard Preston about the origins and incidents involving viral hemorrhagic fevers, particularly ebolaviruses and marburgviruses. The basis of the book was Preston's 1992 New Yorker article "Crisis in the Hot Zone".

<span class="mw-page-title-main">Crimean–Congo hemorrhagic fever</span> Disease of humans and other animals

Crimean–Congo hemorrhagic fever (CCHF) is a viral disease. Symptoms of CCHF may include fever, muscle pains, headache, vomiting, diarrhea, and bleeding into the skin. Onset of symptoms is less than two weeks following exposure. Complications may include liver failure. Survivors generally recover around two weeks after onset.

<span class="mw-page-title-main">Argentine hemorrhagic fever</span> Medical condition

Argentine hemorrhagic fever (AHF) or O'Higgins disease, also known in Argentina as mal de los rastrojos is a hemorrhagic fever and zoonotic infectious disease occurring in Argentina. It is caused by the Junín virus. Its reservoir of infection is the drylands vesper mouse, a rodent found in Argentina and Paraguay.

Clarence James Peters, Jr is a physician, field virologist and former U.S. Army colonel. He is noted for his efforts in trying to stem epidemics of exotic infectious diseases such as the Ebola virus, Hanta virus and Rift Valley fever (RVF). He is an eminent authority on the virology, pathogenesis and epidemiology of hemorrhagic fever viruses.

Lujo is a bisegmented RNA virus—a member of the family Arenaviridae—and a known cause of viral hemorrhagic fever (VHF) in humans. Its name was suggested by the Special Pathogens Unit of the National Institute for Communicable Diseases of the National Health Laboratory Service (NICD-NHLS) by using the first two letters of the names of the cities involved in the 2008 outbreak of the disease, Lusaka (Zambia) and Johannesburg. It is the second pathogenic Arenavirus to be described from the African continent—the first being Lassa virus—and since 2012 has been classed as a "Select Agent" under U.S. law.

<span class="mw-page-title-main">Reston virus</span> Species of Ebola virus

Reston virus (RESTV) is one of six known viruses within the genus Ebolavirus. Reston virus causes Ebola virus disease in non-human primates; out of all 6 ebolaviruses, it is one of the only two not known to cause disease in humans, but has caused asymptomatic infections. Reston virus was first described in 1990 as a new "strain" of Ebola virus (EBOV). It is the single member of the species Reston ebolavirus, which is included into the genus Ebolavirus, family Filoviridae, order Mononegavirales. Reston virus is named after Reston, Virginia, US, where the virus was first discovered.

<span class="mw-page-title-main">Marburg virus</span> Species of filamentous virus responsible for hemorrhagic fever

Marburg virus (MARV) is a hemorrhagic fever virus of the Filoviridae family of viruses and a member of the species Marburg marburgvirus, genus Marburgvirus. It causes Marburg virus disease in primates, a form of viral hemorrhagic fever. The World Health Organization (WHO) rates it as a Risk Group 4 Pathogen. In the United States, the National Institute of Allergy and Infectious Diseases ranks it as a Category A Priority Pathogen and the Centers for Disease Control and Prevention lists it as a Category A Bioterrorism Agent. It is also listed as a biological agent for export control by the Australia Group.

<span class="mw-page-title-main">Hantavirus hemorrhagic fever with renal syndrome</span> Group of clinically similar illnesses caused by species of hantaviruses

Hantavirus hemorrhagic fever with renal syndrome (HFRS) is a group of clinically similar illnesses caused by species of hantaviruses. It is also known as Korean hemorrhagic fever and epidemic hemorrhagic fever. It is found in Europe, Asia, and Africa. The species that cause HFRS include Hantaan orthohantavirus, Dobrava-Belgrade orthohantavirus, Saaremaa virus, Seoul orthohantavirus, Puumala orthohantavirus and other orthohantaviruses. Of these species, Hantaan River virus and Dobrava-Belgrade virus cause the most severe form of the syndrome and have the highest morbidity rates. When caused by the Puumala virus, it is also called nephropathia epidemica. This infection is known as sorkfeber in Swedish, myyräkuume in Finnish, and musepest in Norwegian.

<span class="mw-page-title-main">Ebola</span> Viral hemorrhagic fever of humans and other primates caused by ebolaviruses

Ebola, also known as Ebola virus disease (EVD) and Ebola hemorrhagic fever (EHF), is a viral hemorrhagic fever in humans and other primates, caused by ebolaviruses. Symptoms typically start anywhere between two days and three weeks after infection. The first symptoms are usually fever, sore throat, muscle pain, and headaches. These are usually followed by vomiting, diarrhoea, rash and decreased liver and kidney function, at which point some people begin to bleed both internally and externally. It kills between 25% and 90% of those infected – about 50% on average. Death is often due to shock from fluid loss, and typically occurs between six and 16 days after the first symptoms appear. Early treatment of symptoms increases the survival rate considerably compared to late start. An Ebola vaccine was approved by the US FDA in December 2019.

<span class="mw-page-title-main">1976 Zaire Ebola virus outbreak</span> Outbreak of Ebola virus disease

In August–November 1976, an outbreak of Ebola virus disease occurred in Zaire. The first recorded case was from Yambuku, a small village in Mongala District, 1,098 kilometres (682 mi) northeast of the capital city of Kinshasa.

The 2022–2023 mpox outbreak in Switzerland is a part of the outbreak of human mpox caused by the West African clade of the monkeypox virus. The outbreak started in Switzerland on 19 May 2022, with the country since then becoming one of the most affected in Europe.

<span class="mw-page-title-main">2023 Equatorial Guinea Marburg virus disease outbreak</span> Marburg disease outbreak in Equatorial Guinea

A disease outbreak was first reported in Equatorial Guinea on 7 February 2023 and, on 13 February 2023, it was identified as being Marburg virus disease. It was the first time the disease was detected in the country. As of 4 April 2023, there were 14 confirmed cases and 28 suspected cases, including ten confirmed deaths from the disease in Equatorial Guinea. On 8 June 2023, the World Health Organization declared the outbreak over. In total, 17 laboratory-confirmed cases and 12 deaths were recorded. All the 23 probable cases reportedly died. Four patients recovered from the virus and have been enrolled in a survivors programme to receive psychosocial and other post-recovery support.

A Marburg virus disease outbreak in Tanzania was first reported on 21 March 2023 by the Ministry of Health of Tanzania. This is the first time that Tanzania has reported an outbreak of the disease. On 2 June 2023, Tanzania declared the outbreak over.

<span class="mw-page-title-main">Rwanda Marburg virus disease outbreak</span>

Rwanda is currently experiencing its first-ever outbreak of Marburg virus disease (MVD).The outbreak was first reported to the World Health Organization on September 28, 2024. The U.S. embassy in Rwanda has issued an alert on the matter.

References

  1. "Marburg Hemorrhagic Fever (Marburg HF) | CDC". www.cdc.gov. 25 February 2019. Archived from the original on 19 October 2022. Retrieved 16 February 2020.
  2. 1 2 "Marburg Virus - an overview | ScienceDirect Topics". www.sciencedirect.com. Archived from the original on 2021-10-21. Retrieved 2020-08-12.
  3. 1 2 3 4 Slenczka, Werner; Klenk, Hans Dieter (2007-11-15). "Forty Years of Marburg Virus". The Journal of Infectious Diseases. 196 (Supplement_2): S131–S135. doi: 10.1086/520551 . ISSN   0022-1899. PMID   17940940.
  4. Brauburger, Kristina; Hume, Adam J.; Mühlberger, Elke; Olejnik, Judith (2012-10-01). "Forty-Five Years of Marburg Virus Research". Viruses. 4 (10): 1878–1927. doi: 10.3390/v4101878 . ISSN   1999-4915. PMC   3497034 . PMID   23202446.
  5. "Outbreaks Chronology: Marburg Hemorrhagic Fever | Marburg Hemorrhagic Fever (Marburg HF) | CDC". www.cdc.gov. 2019-02-25. Archived from the original on 2020-05-06. Retrieved 2020-02-16.

Further reading